Cyclin A: A Protein Involved in Cell Division, Growth and Cancer Development

Target Name: Cyclin A

NCBI ID: P10930

Cyclin A

Other Name(s): None

Cyclin A: A Protein Involved in Cell Division, Growth and Cancer Development

Cyclin A (nonspecified subtype) is a protein that is expressed in various cell types of the human body, including neurons, muscle cells, and red blood cells. It plays a crucial role in cell division and growth, and is known to be involved in the development and progression of many diseases, including cancer. As a result, Cyclin A has become an attractive drug target for researchers, with potential applications in a variety of therapeutic areas. In this article, we will explore the biology and functions of Cyclin A , as well as its potential as a drug target.

Structure and Expression
Cyclin A is a member of the T-cell nuclear factor (TNF) family, which includes a variety of transcription factors that regulate cell growth, differentiation, and inflammation. Cyclin A is a 24-kDa protein that consists of a 166 amino acid chain . It has four known isoforms, which are different in their size and localization within the cell. The most abundant is the soluble isoform, which is involved in the cell cycle and plays a role in the development of many diseases. Other isoforms are involved in cell adhesion, migration, and plating, and are involved in the regulation of cell survival and proliferation.

Cyclin A is expressed in a variety of tissues and cells throughout the body, including neurons, muscle cells, and red blood cells. It is highly expressed in the brain, where it is involved in the development and maintenance of neural stem cells, and in the muscle, where it plays a role in muscle growth and repair. Cyclin A is also expressed in other tissues, including the lungs, liver, and pancreas, where it is involved in the regulation of cell growth and differentiation.

Function
The function of Cyclin A is complex and involves a variety of different processes in the cell. It is involved in the regulation of cell cycle progression, which is the process by which cells grow, divide, and replicate their genetic material. Cyclin A helps to control the length of the cell cycle by regulating the activity of the cyclin-dependent kinases (CDKs), which are enzymes that regulate the movement of the chromosomes along the DNA.

In addition to its role in regulating the cell cycle, Cyclin A is also involved in the regulation of cell growth and differentiation. It plays a role in the development and maintenance of neural stem cells, which are a source of new neurons and are involved in the treatment of a variety of neurological and psychiatric disorders. Cyclin A is also involved in the regulation of muscle growth and repair, and is thought to play a role in the development and progression of muscle diseases such as muscular dystrophy.

Cyclin A is also involved in the regulation of cell survival and proliferation. It has been shown to play a role in the regulation of cell survival in a variety of tissues, including the brain. In addition, Cyclin A is involved in the regulation of cell proliferation, and is thought to play a role in the development and progression of cancer.

Drug Targets
Cyclin A has emerged as a promising drug target for a variety of therapeutic areas. One of the main targets for Cyclin A is the treatment of cancer. Cyclin A has been shown to play a role in the development and progression of a variety of cancers, including breast, ovarian, and prostate cancers. As a result, Cyclin A has become a focus of research in the development of new cancer therapies.

In addition to its potential as a cancer therapeutic, Cyclin A has also been shown to be a potential drug target for a variety of other conditions. For example, it has been shown to play a role in the treatment of autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis. It has also been shown to be involved in the regulation of cell signaling pathways, which are involved in a variety of cellular processes

Protein Name: Cyclin A (nonspecified Subtype)

The "Cyclin A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Cyclin A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets